CASI Pharmaceuticals (CASIF) EPS (Basic) (QoQ) (2022 - 2025)
CASI Pharmaceuticals (CASIF) EPS (Basic) (QoQ) (2022 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.69 Bn | 130.84 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.29 Bn | 78.29 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.79 Bn | 59.60 Bn | 1.37 Bn |
| 4 | Moderna | 59.44 Bn | 54.31 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.07 Bn | 36.97 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.92 Bn | 27.61 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.10 Bn | 9.71 Bn | 668.28 Mn |
| 8 | Insmed | 27.33 Bn | 26.17 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.00 Bn | 26.17 Bn | - |
| 10 | CASI Pharmaceuticals | 2.65 Mn | -3.76 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -529.39% |
| Sep 30, 2025 | 6.99% |
| Jun 30, 2025 | -7.46% |
| Mar 31, 2025 | 21.64% |
| Dec 31, 2024 | -55.97% |
| Sep 30, 2024 | 15.01% |
| Jun 30, 2024 | 8.12% |
| Mar 31, 2024 | 85.81% |
| Dec 31, 2023 | -1,020.42% |
| Sep 30, 2023 | 41.66% |
| Jun 30, 2023 | -24.39% |
| Mar 31, 2023 | 92.35% |
| Dec 31, 2022 | -1,526.29% |
| Sep 30, 2022 | 6.70% |
| Jun 30, 2022 | 5.21% |